Madrigal Pharmaceuticals has hired a former Novartis executive to succeed its retiring founder as chief medical officer.

Madrigal Pharmaceuticals (MDGL) announced that Rebecca Taub, M.D., the company’s founder, Chief Medical Officer, and President of Research ...

April 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated ...

In this article, we are going to take a look at where Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) stands against other most expensive stocks insiders are dumping in March. After being in the ...

Madrigal Pharmaceuticals Trading Down 3.9 % Madrigal Pharmaceuticals stock opened at $314.39 on Friday. Madrigal Pharmaceuticals, Inc. has a 1 year low of $189.00 and a 1 year high of $377.46. The ...

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Kiniksa Pharmaceuticals (KNSA – Research Report), with ...

Investors considering a purchase of Madrigal Pharmaceuticals Inc (Symbol: MDGL) shares, but cautious about paying the going market price of $338.56/share, might benefit from considering selling ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...